Literature DB >> 9092710

pH-induced destabilization of lipid bilayers by a lipopeptide derived from influenza hemagglutinin.

A L Bailey1, M A Monck, P R Cullis.   

Abstract

A synthetic twenty-one amino acid peptide (AcE4K) based on the amino acid sequence of the influenza HA2 fusion peptide was coupled to a distearoylglycerol lipid anchor by amidation of an N-terminal lysine side chain. The secondary structure of Lipo-AcE4K incorporated into POPC (1-palmitoyl-2-oleoyl-sn-phosphatidylcholine) liposomes was not measurably affected by pH, but increased membrane penetration was indicated by tryptophan fluorescence. At outer monolayer concentrations up to 10 mol%, Lipo-AcE4K formed stable liposomes with POPC and EPC/Chol (egg phosphatidylcholine/cholesterol) (55:45) at pH 7.5. Acid-induced destabilization and fusion of these vesicles were demonstrated by fluorescent lipid mixing and contents leakage assays, and by freeze-fracture electron microscopy. Membrane destabilization increased with increasing lipopeptide concentrations, decreasing pH, inclusion of cholesterol, and incorporation of lipopeptide into the inner monolayer as well as the outer monolayer of the liposomes. Fusion of liposomes bearing Lipo-AcE4K with erythrocyte ghosts was demonstrated by lipid mixing and fluorescence microscopy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092710     DOI: 10.1016/s0005-2736(96)00228-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

2.  Content Delivery of Lipidic Nanovesicles in Electropermeabilized Cells.

Authors:  P Henri; R Ospital; Justin Teissié
Journal:  J Membr Biol       Date:  2015-03-22       Impact factor: 1.843

3.  Interaction of synthetic HA2 influenza fusion peptide analog with model membranes.

Authors:  D V Zhelev; N Stoicheva; P Scherrer; D Needham
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

4.  Membrane Disruption Mechanism of a Prion Peptide (106-126) Investigated by Atomic Force Microscopy, Raman and Electron Paramagnetic Resonance Spectroscopy.

Authors:  Jianjun Pan; Prasana K Sahoo; Annalisa Dalzini; Zahra Hayati; Chinta M Aryal; Peng Teng; Jianfeng Cai; Humberto Rodriguez Gutierrez; Likai Song
Journal:  J Phys Chem B       Date:  2017-05-10       Impact factor: 2.991

5.  Fusion peptides promote formation of bilayer cubic phases in lipid dispersions. An x-ray diffraction study.

Authors:  Boris G Tenchov; Robert C MacDonald; Barry R Lentz
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

6.  Glucosylceramide Reorganizes Cholesterol-Containing Domains in a Fluid Phospholipid Membrane.

Authors:  Ana R P Varela; André Sá Couto; Aleksander Fedorov; Anthony H Futerman; Manuel Prieto; Liana C Silva
Journal:  Biophys J       Date:  2016-02-02       Impact factor: 4.033

7.  Charged N-terminus of Influenza Fusion Peptide Facilitates Membrane Fusion.

Authors:  Remigiusz Worch; Anita Dudek; Joanna Krupa; Anna Szymaniec; Piotr Setny
Journal:  Int J Mol Sci       Date:  2018-02-14       Impact factor: 5.923

Review 8.  Common properties of fusion peptides from diverse systems.

Authors:  I Martin; J M Ruysschaert
Journal:  Biosci Rep       Date:  2000-12       Impact factor: 3.840

9.  Intracellular Vesicle Fusion Requires a Membrane-Destabilizing Peptide Located at the Juxtamembrane Region of the v-SNARE.

Authors:  Shailendra S Rathore; Yinghui Liu; Haijia Yu; Chun Wan; MyeongSeon Lee; Qian Yin; Michael H B Stowell; Jingshi Shen
Journal:  Cell Rep       Date:  2019-12-24       Impact factor: 9.423

10.  Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers.

Authors:  Loredana Vaccaro; Karen J Cross; Jens Kleinjung; Suzana K Straus; David J Thomas; Stephen A Wharton; John J Skehel; Franca Fraternali
Journal:  Biophys J       Date:  2004-10-08       Impact factor: 4.033

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.